← back to search

Gui-Feng Deng

Shanxi Medical University · CN
Area of research
Molecular Biology · Physiology
Research interest
Research topics from publications: Shaoyao-Gancao Decoction Ameliorates the Inflammation State in Polycystic Ovary Syndrome Rats via Remodeling Gut Microbiota and Suppressing the TLR4/NF-κB Pathway; Oridonin Attenuates TNBS-induced Post-inflammatory Irritable Bowel Syndrome via PXR/NF-κB Signaling; Shaoyao‐Gancao Decoction Relieves Visceral Hyperalgesia in TNBS‐Induced Postinflammatory Irritable Bowel Syndrome via Inactivating Transient Receptor Potential Vanilloid Type 1 and Reducing Serotonin Synthesis. Representative work: Background: Emerging evidence suggests that gut microbiota plays a vital role in the occurrence of multiple endocrine disorders including polycystic ovary syndrome (PCOS). Shaoyao-Gancao Decoction (SGD), a classical Chinese prescription, has been widely used in the treatment of PCOS for decades. In previous studies, we found that SGD treatment could effectively reduce ovarian inflammation in PCOS rats. However, whether the anti-inflammation effect of SGD involves the regulation of the gut microbiota remains elusive. Methods: Letrozole-induced PCOS rat models were established, and the therapeutic effects of SGD were evaluated. Specifically, body weight, serum hormone concentrations, estrus ph Postinflammatory irritable bowel syndrome (PI-IBS) is a common functional gastrointestinal disorder, which is characterized by abdominal pain, low-grade inflammation, and visceral hypersensitivity. Shaoyao-Gancao decoction (SGD) has been used to improve the clinical symptoms of abdominal spasmodic pain accompanying acute gastroenteritis, but the underlying therapeutic mechanism has not been fully elucidated. In the present study, a rat model of PI-IBS was established via rectal administration of TNBS. Rats were scored daily for 28 days using disease activity index (DAI). Abdominal withdrawal reflex (AWR) was used to measure the pain threshold. After SGD (6.25, 12.5, and 25 g/kg/d) treatment
h-index
citations
0
works
0
NIH funding
primary concept
email

Recent publications

Shaoyao-Gancao Decoction Ameliorates the Inflammation State in Polycystic Ovary Syndrome Rats via Remodeling Gut Microbiota and Suppressing the TLR4/NF-κB Pathway
Frontiers in Pharmacology 2021cited by 77position: middledoi
Oridonin Attenuates TNBS-induced Post-inflammatory Irritable Bowel Syndrome via PXR/NF-κB Signaling
Inflammation 2020cited by 40position: middledoi
Shaoyao‐Gancao Decoction Relieves Visceral Hyperalgesia in TNBS‐Induced Postinflammatory Irritable Bowel Syndrome via Inactivating Transient Receptor Potential Vanilloid Type 1 and Reducing Serotonin Synthesis
Evidence-based Complementary and Alternative Medicine 2020cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ruigang Hou · Shanxi Medical University3 papers (2020–2021)Junjin Liu · Shanxi Medical University3 papers (2020–2021)Zhuang‐peng Chang · Shanxi Medical University3 papers (2020–2021)Yun‐yun Shao · Shanxi Medical University3 papers (2020–2021)Jianping Gao · Shanxi Medical University2 papers (2020–2020)Xu Ding · Shanxi Medical University2 papers (2020–2020)Yao Guo · Chongqing University1 papers (2020–2020)Xiaojuan Feng · Sichuan University1 papers (2020–2020)Xiaojuan Feng · Hebei Medical University1 papers (2020–2020)Ding Xu · Shanxi Medical University1 papers (2021–2021)Yiting Guo · Shandong University1 papers (2020–2020)Yifan Sun · Jiangsu University1 papers (2021–2021)Yinan Zhao · Xiamen University1 papers (2021–2021)